Clinical Trial Update: S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 study S0112 evaluated cytarabine plus daunorubicin in older patients with acute myeloid leukemia; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Leukemia | Phase 2 | Status: COMPLETED